Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 417

1.

Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor.

Thurnher MM, Boban J, Rieger A, Gelpi E.

AJNR Am J Neuroradiol. 2019 Jun;40(6):994-1000. doi: 10.3174/ajnr.A6072. Epub 2019 May 23.

PMID:
31122919
2.

Teaching case 3-2019: Are nuclear clefts or invaginations the niche of intranuclear inclusions in FTLD-TDP?

Molina-Porcel L, Pérez-Navarro E, García-Forn M, Westaway D, Colom-Cadena M, Gelpi E.

Clin Neuropathol. 2019 May/Jun;38(3):97-99. doi: 10.5414/NP301202. No abstract available.

PMID:
31023421
3.

Nanoscale structure of amyloid-β plaques in Alzheimer's disease.

Querol-Vilaseca M, Colom-Cadena M, Pegueroles J, Nuñez-Llaves R, Luque-Cabecerans J, Muñoz-Llahuna L, Andilla J, Belbin O, Spires-Jones TL, Gelpi E, Clarimon J, Loza-Alvarez P, Fortea J, Lleó A.

Sci Rep. 2019 Mar 26;9(1):5181. doi: 10.1038/s41598-019-41443-3.

4.

Combined Transcriptomics and Proteomics in Frontal Cortex Area 8 in Frontotemporal Lobar Degeneration Linked to C9ORF72 Expansion.

Andrés-Benito P, Gelpi E, Povedano M, Ausín K, Fernández-Irigoyen J, Santamaría E, Ferrer I.

J Alzheimers Dis. 2019;68(3):1287-1307. doi: 10.3233/JAD-181123.

PMID:
30909235
5.

Fragile X-associated tremor/ataxia syndrome: Regional decrease of mitochondrial DNA copy number relates to clinical manifestations.

Alvarez-Mora MI, Podlesniy P, Gelpi E, Hukema R, Madrigal I, Pagonabarraga J, Trullas R, Mila M, Rodriguez-Revenga L.

Genes Brain Behav. 2019 Jun;18(5):e12565. doi: 10.1111/gbb.12565. Epub 2019 May 24.

PMID:
30887649
6.

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2019 Mar 18. doi: 10.1002/mds.27666. [Epub ahead of print]

PMID:
30884545
7.

Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis.

Carballo-Carbajal I, Laguna A, Romero-Giménez J, Cuadros T, Bové J, Martinez-Vicente M, Parent A, Gonzalez-Sepulveda M, Peñuelas N, Torra A, Rodríguez-Galván B, Ballabio A, Hasegawa T, Bortolozzi A, Gelpi E, Vila M.

Nat Commun. 2019 Mar 7;10(1):973. doi: 10.1038/s41467-019-08858-y.

8.

Accumulation of prion protein in the vagus nerve in creutzfeldt-jakob disease.

Kresl P, Rahimi J, Gelpi E, Aldecoa I, Ricken G, Danics K, Keller E, Kovacs GG.

Ann Neurol. 2019 May;85(5):782-787. doi: 10.1002/ana.25451. Epub 2019 Mar 11.

PMID:
30801763
9.

Diagnostic challenges and pitfalls of myelin oligodendrocyte glycoprotein antibody-associated demyelination: Lessons from neuropathology.

Höftberger R, Gelpi E.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 1;6(2):e544. doi: 10.1212/NXI.0000000000000544. eCollection 2019 Mar. No abstract available.

10.

Co-morbid demyelinating lesions and atypical clinical features in a patient with Parkinson's disease.

Rodriguez-Diehl R, Vilas D, Bargalló N, Tolosa E, Gelpi E.

Parkinsonism Relat Disord. 2019 May;62:242-245. doi: 10.1016/j.parkreldis.2019.01.015. Epub 2019 Feb 2. No abstract available.

PMID:
30738747
11.

Macrophagic scavenging of Aβ.

Gelpi E, Klotz S, Lang A, Stögmann E, Kovacs GG.

Clin Neuropathol. 2019 Mar/Apr;38(2):48-50. doi: 10.5414/NP301175. No abstract available.

PMID:
30704554
12.

Oligomers: a hot topic for neurodegeneration and a note of caution for experimental models.

Gelpi E, Colom-Cadena M.

Brain. 2019 Feb 1;142(2):228-230. doi: 10.1093/brain/awy342. No abstract available.

PMID:
30698762
13.

Lymphomatosis cerebri and anti-NMDAR antibodies: A unique constellation.

Mariotto S, Zamó A, Franchini E, Bonetti B, Parisi A, Höftberger R, Gelpi E, Monaco S, Ferrari S.

J Neurol Sci. 2019 Mar 15;398:19-21. doi: 10.1016/j.jns.2019.01.014. Epub 2019 Jan 14. No abstract available.

PMID:
30682517
14.

Myoclonus-Dominant Corticobasal Degeneration.

Caballol N, Navarro-Otano J, Ávila A, Balagué-Marmaña M, Martínez-Fernández R, de Fàbregas O, Gelpí E, Valls-Solé J, Tolosa E.

Mov Disord Clin Pract. 2018 Nov 6;5(6):649-652. doi: 10.1002/mdc3.12670. eCollection 2018 Nov-Dec. No abstract available.

PMID:
30637289
15.

An Integrative Study of Protein-RNA Condensates Identifies Scaffolding RNAs and Reveals Players in Fragile X-Associated Tremor/Ataxia Syndrome.

Cid-Samper F, Gelabert-Baldrich M, Lang B, Lorenzo-Gotor N, Ponti RD, Severijnen LWFM, Bolognesi B, Gelpi E, Hukema RK, Botta-Orfila T, Tartaglia GG.

Cell Rep. 2018 Dec 18;25(12):3422-3434.e7. doi: 10.1016/j.celrep.2018.11.076.

16.

Case of the month 1-2019: CNS high-grade neuroepithelial tumor with BCOR alteration.

Haberler C, Reiniger L, Rajnai H, Kalev O, Gelpi E, Tamesberger M, Pietsch T.

Clin Neuropathol. 2019 Jan/Feb;38(1):4-7. doi: 10.5414/NP301162. No abstract available.

17.

Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.

Borrego-Écija S, Cortés-Vicente E, Cervera-Carles L, Clarimón J, Gámez J, Batlle J, Ricken G, Molina-Porcel L, Aldecoa I, Sánchez-Valle R, Rojas-García R, Gelpi E.

Neuropathol Appl Neurobiol. 2019 Jun;45(4):421-426. doi: 10.1111/nan.12527. Epub 2018 Nov 20. No abstract available.

PMID:
30375034
18.

Variably protease-sensitive prionopathy presenting within ALS/FTD spectrum.

Vicente-Pascual M, Rossi M, Gámez J, Lladó A, Valls J, Grau-Rivera O, Ávila Polo R, Llorens F, Zerr I, Ferrer I, Nos C, Parchi P, Sánchez-Valle R, Gelpí E.

Ann Clin Transl Neurol. 2018 Sep 21;5(10):1297-1302. doi: 10.1002/acn3.632. eCollection 2018 Oct.

19.

Clinical Neuropathology image 6-2018: Metastasis of breast carcinoma to meningioma.

Klotz S, Matula C, Pones M, Herac M, Grisold A, Hainfellner JA, Kovacs GG, Gelpi E.

Clin Neuropathol. 2018 Nov/Dec;37(6):252-253. doi: 10.5414/NP301150. No abstract available.

20.

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.

Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, Fox NC, Sanchez-Valle R, Grau-Rivera O, Gelpi E, Seelaar H, Papma JM, van Swieten JC, Hodges JR, Leyton CE, Piguet O, Rogalski EJ, Mesulam MM, Koric L, Nora K, Pariente J, Dickerson B, Mackenzie IR, Hsiung GR, Belliard S, Irwin DJ, Wolk DA, Grossman M, Jones M, Harris J, Mann D, Snowden JS, Chrem-Mendez P, Calandri IL, Amengual AA, Miguet-Alfonsi C, Magnin E, Magnani G, Santangelo R, Deramecourt V, Pasquier F, Mattsson N, Nilsson C, Hansson O, Keith J, Masellis M, Black SE, Matías-Guiu JA, Cabrera-Martin MN, Paquet C, Dumurgier J, Teichmann M, Sarazin M, Bottlaender M, Dubois B, Rowe CC, Villemagne VL, Vandenberghe R, Granadillo E, Teng E, Mendez M, Meyer PT, Frings L, Lleó A, Blesa R, Fortea J, Seo SW, Diehl-Schmid J, Grimmer T, Frederiksen KS, Sánchez-Juan P, Chételat G, Jansen W, Bouchard RW, Laforce RJ, Visser PJ, Ossenkoppele R.

Ann Neurol. 2018 Nov;84(5):729-740. doi: 10.1002/ana.25333.

21.

α-Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa.

Skorvanek M, Gelpi E, Mechirova E, Ladomirjakova Z, Han V, Lesko N, Feketeova E, Repkova B, Urbancikova Z, Vargova A, Spisak P, Ribeiro Ventosa J, Kudela F, Kulcsarova K, Babinska S, Toth S, Gombosova L, Zakuciova M, Veseliny E, Trebuna F, Lutz MI, Gdovinova Z, Kovacs GG; PARCAS studygroup.

Mov Disord. 2018 Aug;33(8):1366-1368. doi: 10.1002/mds.27380. No abstract available.

PMID:
30230627
22.

Alpha-synuclein aggregates in the parotid gland of idiopathic REM sleep behavior disorder.

Fernández-Arcos A, Vilaseca I, Aldecoa I, Serradell M, Tolosa E, Santamaría J, Gelpi E, Iranzo A.

Sleep Med. 2018 Dec;52:14-17. doi: 10.1016/j.sleep.2018.08.003. Epub 2018 Aug 14.

PMID:
30195197
23.

Teaching Case 5-2018: Integrated morphological and immunological work-up of neurosurgical specimen allows accurate diagnosis of neuroinflammatory lesions: an example of acute disseminated encephalomyelitis (ADEM) associated with anti-MOG antibodies.

Lang J, Biebl A, Gruber A, Maier-Hiebl B, Hainfellner JA, Höftberger R, Gelpi E.

Clin Neuropathol. 2018 Sep/Oct;37(5):206-208. doi: 10.5414/NP301136. No abstract available.

24.

Lack of central and peripheral nervous system synuclein pathology in R1441G LRRK2-associated Parkinson's disease.

Vilas D, Gelpi E, Aldecoa I, Grau O, Rodriguez-Diehl R, Jaumà S, Martí MJ, Tolosa E.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):832-833. doi: 10.1136/jnnp-2018-318473. Epub 2018 Jul 27. No abstract available.

PMID:
30054313
25.

Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges.

Abu-Rumeileh S, Redaelli V, Baiardi S, Mackenzie G, Windl O, Ritchie DL, Didato G, Hernandez-Vara J, Rossi M, Capellari S, Imperiale D, Rizzone MG, Belotti A, Sorbi S, Rozemuller AJM, Cortelli P, Gelpi E, Will RG, Zerr I, Giaccone G, Parchi P.

Ann Neurol. 2018 Sep;84(3):347-360. doi: 10.1002/ana.25300. Epub 2018 Aug 31.

PMID:
30048013
26.

Systematic Screening of Ubiquitin/p62 Aggregates in Cerebellar Cortex Expands the Neuropathological Phenotype of the C9orf72 Expansion Mutation.

Ramos-Campoy O, Ávila-Polo R, Grau-Rivera O, Antonell A, Clarimón J, Rojas-García R, Charif S, Santiago-Valera V, Hernandez I, Aguilar M, Almenar C, Lopez-Villegas D, Bajo L, Pastor P, Van der Zee J, Lladó A, Sanchez-Valle R, Gelpi E.

J Neuropathol Exp Neurol. 2018 Aug 1;77(8):703-709. doi: 10.1093/jnen/nly047.

PMID:
29889265
27.

Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia.

Cortés-Vicente E, Turon-Sans J, Gelpi E, Clarimón J, Borrego-Écija S, Dols-Icardo O, Illán-Gala I, Lleó A, Illa I, Blesa R, Al-Chalabi A, Rojas-García R.

Dement Geriatr Cogn Disord. 2018;45(3-4):220-231. doi: 10.1159/000488528. Epub 2018 Jun 8.

PMID:
29886477
28.

No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients.

Baradaran-Heravi Y, Dillen L, Nguyen HP, Van Mossevelde S, Baets J, De Jonghe P, Engelborghs S, De Deyn PP, Vandenbulcke M, Vandenberghe R, Van Damme P, Cras P, Salmon E, Synofzik M, Heutink P, Wilke C, Simon-Sanchez J, Rojas-Garcia R, Turon-Sans J, Lleó A, Illán-Gala I, Clarimón J, Borroni B, Padovani A, Pastor P, Diez-Fairen M, Aguilar M, Gelpi E, Sanchez-Valle R, Borrego-Ecija S, Matej R, Parobkova E, Nacmias B, Sorbi S, Bagnoli S, de Mendonça A, Ferreira C, Fraidakis MJ, Diehl-Schmid J, Alexopoulos P, Almeida MR, Santana I, Van Broeckhoven C, van der Zee J; BELNEU Consortium; EU EOD Consortium.

Neurobiol Aging. 2018 Sep;69:293.e9-293.e11. doi: 10.1016/j.neurobiolaging.2018.05.005. Epub 2018 May 23.

29.

Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD?

Orimo S, Ghebremedhin E, Gelpi E.

Cell Tissue Res. 2018 Jul;373(1):267-286. doi: 10.1007/s00441-018-2851-9. Epub 2018 Jun 4. Review.

PMID:
29869180
30.

α-Synuclein aggregates in labial salivary glands of idiopathic rapid eye movement sleep behavior disorder.

Iranzo A, Borrego S, Vilaseca I, Martí C, Serradell M, Sánchez-Valle R, Kovacs GG, Valldeoriola F, Gaig C, Santamaria J, Tolosa E, Gelpi E.

Sleep. 2018 Aug 1;41(8). doi: 10.1093/sleep/zsy101.

PMID:
29790977
31.

Gene Expression Profile in Frontal Cortex in Sporadic Frontotemporal Lobar Degeneration-TDP.

Andrés-Benito P, Gelpi E, Povedano M, Santpere G, Ferrer I.

J Neuropathol Exp Neurol. 2018 Jul 1;77(7):608-627. doi: 10.1093/jnen/nly037.

PMID:
29788265
32.

Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease.

Dekker AD, Vermeiren Y, Carmona-Iragui M, Benejam B, Videla L, Gelpi E, Aerts T, Van Dam D, Fernández S, Lleó A, Videla S, Sieben A, Martin JJ; Netherlands Brain Bank, Blesa R, Fortea J, De Deyn PP.

Alzheimers Dement (Amst). 2017 Nov 23;10:99-111. doi: 10.1016/j.dadm.2017.11.001. eCollection 2018.

33.

Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia.

Philtjens S, Van Mossevelde S, van der Zee J, Wauters E, Dillen L, Vandenbulcke M, Vandenberghe R, Ivanoiu A, Sieben A, Willems C, Benussi L, Ghidoni R, Binetti G, Borroni B, Padovani A, Pastor P, Diez-Fairen M, Aguilar M, de Mendonça A, Miltenberger-Miltényi G, Hernández I, Boada M, Ruiz A, Nacmias B, Sorbi S, Almeida MR, Santana I, Clarimón J, Lleó A, Frisoni GB, Sanchez-Valle R, Lladó A, Gómez-Tortosa E, Gelpi E, Van den Broeck M, Peeters K, Cras P, De Deyn PP, Engelborghs S, Cruts M, Van Broeckhoven C; BELNEU Consortium; EU EOD Consortium.

Neurobiol Aging. 2018 Jun;66:181.e3-181.e10. doi: 10.1016/j.neurobiolaging.2018.02.011. Epub 2018 Feb 17.

34.

Tauopathy with Hippocampal 4-Repeat Tau Immunoreactive Spherical Inclusions in a Patient with PSP.

Borrego-Écija S, Grau-Rivera O, Colom-Cadena M, Molinuevo JL, Tolosa E, Sánchez-Valle R, Gelpi E.

Brain Pathol. 2018 Mar;28(2):284-286. doi: 10.1111/bpa.12506. No abstract available.

PMID:
29516660
35.

Teaching Case 2-2018: Sclerosing myxopapillary ependymoma mimicking whorling-sclerosing meningioma.

Lang J, Czech T, Slavc I, Reisinger D, Bartsch S, Hainfellner JA, Haberler C, Gelpi E.

Clin Neuropathol. 2018 Mar/Apr;37(2):51-52. doi: 10.5414/NP301099. No abstract available.

36.

Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.

Recasens A, Carballo-Carbajal I, Parent A, Bové J, Gelpi E, Tolosa E, Vila M.

Acta Neuropathol Commun. 2018 Feb 8;6(1):8. doi: 10.1186/s40478-018-0509-1.

37.

Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease.

Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, Vieira-Saecker A, Schwartz S, Santarelli F, Kummer MP, Griep A, Gelpi E, Beilharz M, Riedel D, Golenbock DT, Geyer M, Walter J, Latz E, Heneka MT.

Nature. 2017 Dec 20;552(7685):355-361. doi: 10.1038/nature25158.

PMID:
29293211
38.

Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.

Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Muñoz L, Querol-Vilaseca M, Martín-Paniello CS, Luque-Cabecerans J, Clarimon J, Belbin O, Núñez-Llaves R, Blesa R, Smith C, McKenzie CA, Frosch MP, Roe A, Fortea J, Andilla J, Loza-Alvarez P, Gelpi E, Hyman BT, Spires-Jones TL, Lleó A.

Brain. 2017 Dec 1;140(12):3204-3214. doi: 10.1093/brain/awx275.

39.

Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort.

Verheijen J, van der Zee J, Gijselinck I, Van den Bossche T, Dillen L, Heeman B, Gómez-Tortosa E, Lladó A, Sanchez-Valle R, Graff C, Pastor P, Pastor MA, Benussi L, Ghidoni R, Binetti G, Clarimon J, de Mendonça A, Gelpi E, Tsolaki M, Diehl-Schmid J, Nacmias B, Almeida MR, Borroni B, Matej R, Ruiz A, Engelborghs S, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, Sleegers K; BELNEU Consortium; EU EOD Consortium.

Neurobiol Aging. 2018 Feb;62:245.e1-245.e7. doi: 10.1016/j.neurobiolaging.2017.10.012. Epub 2017 Oct 25.

40.

Hyperspectral Raman imaging of neuritic plaques and neurofibrillary tangles in brain tissue from Alzheimer's disease patients.

Michael R, Lenferink A, Vrensen GFJM, Gelpi E, Barraquer RI, Otto C.

Sci Rep. 2017 Nov 15;7(1):15603. doi: 10.1038/s41598-017-16002-3.

41.

Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers.

Vilas D, Sharp M, Gelpi E, Genís D, Marder KS, Cortes E, Vonsattel JP, Tolosa E, Alcalay RN.

Mov Disord. 2018 Feb;33(2):335-338. doi: 10.1002/mds.27225. Epub 2017 Nov 9. No abstract available.

PMID:
29119599
42.

Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain.

Borrego-Écija S, Morgado J, Palencia-Madrid L, Grau-Rivera O, Reñé R, Hernández I, Almenar C, Balasa M, Antonell A, Molinuevo JL, Lladó A, Martínez de Pancorbo M, Gelpi E, Sánchez-Valle R.

Dement Geriatr Cogn Disord. 2017;44(3-4):213-221. doi: 10.1159/000480077. Epub 2017 Sep 22.

PMID:
28934750
43.

Neuronal intranuclear (hyaline) inclusion disease and fragile X-associated tremor/ataxia syndrome: a morphological and molecular dilemma.

Gelpi E, Botta-Orfila T, Bodi L, Marti S, Kovacs G, Grau-Rivera O, Lozano M, Sánchez-Valle R, Muñoz E, Valldeoriola F, Pagonabarraga J, Tartaglia GG, Milà M.

Brain. 2017 Aug 1;140(8):e51. doi: 10.1093/brain/awx156. No abstract available.

PMID:
28899011
44.

Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the C9orf72 expansion mutation.

Dols-Icardo O, García-Redondo A, Rojas-García R, Borrego-Hernández D, Illán-Gala I, Muñoz-Blanco JL, Rábano A, Cervera-Carles L, Juárez-Rufián A, Spataro N, De Luna N, Galán L, Cortes-Vicente E, Fortea J, Blesa R, Grau-Rivera O, Lleó A, Esteban-Pérez J, Gelpi E, Clarimón J.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):162-168. doi: 10.1136/jnnp-2017-316820. Epub 2017 Sep 9.

PMID:
28889094
45.

Incidental neuronal intermediate filament inclusion pathology: unexpected biopsy findings in a 37-year-old woman with epilepsy.

Gelpi E, Carrato C, Grau-López L, Becerra JL, Garcia-Armengol R, Massuet A, Cervera-Carles L, Clarimon J, Beyer K, Álvarez R.

Neuropathol Appl Neurobiol. 2017 Dec;43(7):636-640. doi: 10.1111/nan.12441. No abstract available.

PMID:
28880406
46.

Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.

Garcia-Esparcia P, Sideris-Lampretsas G, Hernandez-Ortega K, Grau-Rivera O, Sklaviadis T, Gelpi E, Ferrer I.

Am J Neurodegener Dis. 2017 Jun 15;6(2):15-25. eCollection 2017.

47.

Clinical Neuropathology image 4-2017: High-resolution 7 Tesla MRI of postmortem brain specimens: improving neuroimaging-neuropathology correlations.

Guasp-Verdaguer M, Grau-Rivera O, Prats-Galino A, Bargalló N, Sánchez-Valle R, Gelpi E, Soria G.

Clin Neuropathol. 2017 Jul/Aug;36(4):162-163. doi: 10.5414/NP301049. Review. No abstract available.

48.

Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).

Kovacs GG, Xie SX, Lee EB, Robinson JL, Caswell C, Irwin DJ, Toledo JB, Johnson VE, Smith DH, Alafuzoff I, Attems J, Bencze J, Bieniek KF, Bigio EH, Bodi I, Budka H, Dickson DW, Dugger BN, Duyckaerts C, Ferrer I, Forrest SL, Gelpi E, Gentleman SM, Giaccone G, Grinberg LT, Halliday GM, Hatanpaa KJ, Hof PR, Hofer M, Hortobágyi T, Ironside JW, King A, Kofler J, Kövari E, Kril JJ, Love S, Mackenzie IR, Mao Q, Matej R, McLean C, Munoz DG, Murray ME, Neltner J, Nelson PT, Ritchie D, Rodriguez RD, Rohan Z, Rozemuller A, Sakai K, Schultz C, Seilhean D, Smith V, Tacik P, Takahashi H, Takao M, Rudolf Thal D, Weis S, Wharton SB, White CL 3rd, Woulfe JM, Yamada M, Trojanowski JQ.

J Neuropathol Exp Neurol. 2017 Jul 1;76(7):605-619. doi: 10.1093/jnen/nlx041.

49.

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Höglinger GU; Movement Disorder Society-Endorsed PSP Study Group.

Mov Disord. 2017 Jul;32(7):995-1005. doi: 10.1002/mds.27034. Epub 2017 May 13. Review.

50.

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3.

Supplemental Content

Support Center